In 95 patients with electrical storm, those with refractory ventricular arrhythmias had significantly higher plasma NPY, with NPY >44.4 pg/mL (sensitivity 0.91, specificity 0.90) independently predicting mortality risk.
91% sensitivity for mortality predictionNPY >44.4 pg/mL identified patients at high mortality risk from electrical storm with exceptional accuracy—a simple blood test for a life-threatening condition
What the researchers found
Refractory ES: significantly higher NPY vs controls. NPY threshold: 44.4 pg/mL (sensitivity 0.91, specificity 0.90). High NPY: significantly worse survival (Kaplan-Meier). Cox: NPY independently associated with mortality (95% CI 0.89-0.99). 95 patients (62 control, 33 refractory).
Why it matters
Electrical storm is a cardiac emergency with high mortality. Having a blood test (NPY >44.4 pg/mL) that identifies high-risk patients with 91% sensitivity could enable earlier aggressive intervention.
How the study worked
Prospective cohort. 95 ES patients (62 drug-responsive, 33 refractory). Plasma NPY by ELISA. ROC analysis. Kaplan-Meier survival. Cox proportional hazards.
What this study cannot tell us
Small study (95 patients). Single center. NPY as a single measurement. Prospective but not validated externally. Cannot determine if NPY causes or reflects worse outcomes.
How to read the evidence
Prospective cohort with ROC and survival analysis. Good biomarker discovery data needing external validation.
When this study was published
Published in 2025.
The bigger picture
NPY, released by the sympathetic nervous system during cardiac stress, emerges as both a mechanistic mediator and prognostic marker in life-threatening arrhythmias. This connects neuropeptide biology with cardiac electrophysiology.
Questions still open
- Could NPY-lowering therapies improve ES outcomes?
- Should NPY be measured routinely in ES patients?
- Does NPY promote arrhythmias through direct cardiac effects?
Common questions
What is electrical storm and why is NPY relevant?
Could measuring NPY save lives in electrical storm?
Read the original research
Neuropeptide Y as a Prognostic Biomarker in Electrical Storm.
JACC. Clinical electrophysiology, 11(4), 655-663
Citation
Tang, Jianjun; Liu, Chengfeng; Wang, Zhuo; Zhu, Tongjian; Zhong, Min; Li, Yasai; Chen, Mingxian. (2025). Neuropeptide Y as a Prognostic Biomarker in Electrical Storm.. JACC. Clinical electrophysiology, 11(4), 655-663. https://doi.org/10.1016/j.jacep.2024.11.021